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INITIAL HEART RATE VARIABILITY COULD HELP 
TO IDENTIFY THE PATIENTS WITH MYOTONIC 
DYSTROPHY AT RISK OF DEATH
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Heart rate variability evaluation (HRV) is used to evaluate the prognosis 
in heart diseases at risk of cardiac mortality. Myotonic dystrophy (MD) 
is complicated by cardiac involvement. The purpose of the study 
was to evaluate the prognostic value of HRV determination for the 
strati cation risk in MD.
Methods — 60 asymptomatic patients, 26 men, 34 women, mean 
age 39±12 years at inclusion, had a MD. The studies were performed 
at inclusion and repeated 4±2.5 years later. Recording of 24 hour 
Holter monitoring and measurement of HRV in the time domain was 
calculated every 5 minutes (Elatec system); standard deviation of 
mean RR intervals (SDNN) was determined. Left ventricular ejection 
fraction (LVEF) was evaluated by 2D echocardiography.
Results — 1 — General changes of studies: LVEF tended to decrease 
(63±8, 61.5±19.5 %) (p< 0.06). Mean values of SDNN did not 
change between the  rst inclusion (129±41 ms) and the last study 
(134±51 ms).
2 — Modi cations of studies according to initial data: LVEF was normal 
in 56 patients at inclusion. And decreased at second study 64±6 %, 
61.5±7 % (p<0.01). LVEF was less than 50 % in 4 patients at inclusion 
and did not change at second study (43.5±7 vs 45±8 %). At inclusion, 
SDNN was normal in 42 patients (>100 ms) (147±35 ms) and was 148±52 
at second study (NS); SDNN was < 100 ms in 2 of them at second study. 
SDNN was decreased (50 to 100 ms) in 17 patients at inclusion (mean 
85±9 ms) and tended to increase at second study (97±34 ms) (NS).
3 — Follow-up: Initial SDNN could be predictive of the mortality: four 
patients died from heart and respiratory failure ; Three had an initial 
SDNN < 100 ms (3/17 ; 18 %) and the last one had a normal SDNN (1/42 ; 
2 %) (p < 0.08).
Conclusions — The modi cations of HRV during the follow-up were not 
useful for the prediction of the adverse events in myotonic dystrophy, 
although LVEF decreased with time. However, a relatively low HRV at 
the  rst evaluation could be predictive of increasing mortality from 
2 to 18 %.
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Background — Aldosterone stimulates cardiac collagen synthesis. 
Circulating biomarkers of collagen turnover provide a useful 
tool for the assessment of cardiac remodelling in patients with 
congestive heart failure (CHF) and left ventricular systolic 
dysfunction (LVSD) post acute myocardial infarction (AMI).
Methods and Results — In a substudy of EPHESUS, which evaluated 
the effects of the selective aldosterone-receptor antagonist 
eplerenone versus placebo, serum levels of collagen biomarkers 
were measured in 476 patients with CHF following AMI complicated 
with LVSD. Combination of both ICTP and BNP levels above median 
at baseline was associated with all cause mortality and composite 
endpoint CV death or HF hospitalisation with hazard ratios of 
2.49 (p = 0.039) and 3.03 (p = 0.002) respectively. During follow 
up, PINP and PIIINP levels were found consistently lower in the 
eplerenone group and signi cantly so from month 6 onwards.
Conclusions — Changes in biomarkers of collagen synthesis and 
degradation suggest that extra cellular matrix remodelling is an 
active process in patients with CHF and LVSD post-AMI. High ICTP 
when combined with high BNP serum levels are associated with 
the highest event rate. Eplerenone suppresses post-AMI collagen 
turn over changes.
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Left ventricular hypertrophy (LVH) is an adaptive response to 
chronic biomechanical stress that later progresses to maladaptive 
hypertrophy and heart failure. To better understand the 
mechanisms responsible for LVH development, we studied the 
activation of two major kinases, protein kinase B (Akt/PKB) 
and glycogen synthase kinase3b (GSK3b) and of a phosphatase, 
calcineurin (Cn) in an experimental model of thoracic aorta 
constriction (TAC).
Methods — 4 week-old B6D2/F1 male, Sham-operated (Sham) and 
TAC mice were studied 3, 7, 15, 30 and 60 days post-TAC. Gene 
expression and activation of signalling pathways was studied by 
PCR and Western Blot.
Results — TAC-induced LVH (10 — 51 % at days 3-60, respectively) 
was associated with: 1) fetal gene reexpression characterised by 
an increase in mRNA levels of BNP (1.7-3 fold) and a-SK (2-4 fold), 
an a- to b-MHC switch seen at day 30 only ; 2) a signi cant increase 
in SERCA2a (1.7 fold), PLB, and NCX (3.6 fold) protein levels at 
day 7. 3) a 2 fold increase in P-Akt at day 3 and a decrease at 
day 15 while Akt was increased at days 7 and 15 ; 4) an increase 
in P-GSK3b at day 15 (1.5 fold), whereas no change in Akt and 
GSK3b protein levels were seen at days 30 and 60 ; 5) a signi cant 
decrease in CnAb at day 15 (2 fold).
